Premium
Identification of an HLA‐A24‐restricted cytotoxic T lymphocyte epitope from human papillomavirus type‐16 E6: The combined effects of bortezomib and interferon‐γ on the presentation of a cryptic epitope
Author(s) -
Morishima Satoko,
Akatsuka Yoshiki,
Nawa Akihiro,
Kondo Eisei,
Kiyono Tohru,
Torikai Hiroki,
Nakanishi Toru,
Ito Yoshinori,
Tsujimura Kunio,
Iwata Kosuke,
Ito Koji,
Kodera Yoshihisa,
Morishima Yasuo,
Kuzushima Kiyotaka,
Takahashi Toshitada
Publication year - 2006
Publication title -
international journal of cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.475
H-Index - 234
eISSN - 1097-0215
pISSN - 0020-7136
DOI - 10.1002/ijc.22312
Subject(s) - epitope , cytotoxic t cell , ctl* , virology , biology , cancer research , immunotherapy , immunology , human leukocyte antigen , cervical cancer , antigen , cancer , cd8 , immune system , in vitro , biochemistry , genetics
About 50% of cervical cancers are associated with human papillomavirus type 16 (HPV‐16), and since the HPV‐16 E6 and E7 oncoproteins are constitutively expressed in the tumor cells, they are attractive targets for cytotoxic T lymphocyte (CTL)‐mediated immunotherapy. Nevertheless, only a limited number of HPV‐16 E6 epitopes have been identified to date. Using reverse immunological methods, we have generated a CTL clone against the HPV‐16 E6 49–57 epitope restricted by HLA‐A*2402, which is the most common allele in Japan and relatively frequent worldwide, capable of lysing 293T cells transduced with HLA‐A*2402 and HPV‐16 E6. Although it was unable to recognize the SiHa cervical cancer cell line positive for HPV‐16 and HLA‐A*2402, the cells became susceptible to lysis when transduced with E6‐E7 genes, which was unexpectedly offset by pretreatment with interferon (IFN)‐γ alone. Interestingly, however, combined pretreatment with a proteasome inhibitor, bortezomib and IFN‐γ fully restored CTL‐mediated lysis of the original SiHa cells. Furthermore, such intervention of 2 of 4 other cervical cancer cell lines expressing HPV‐16 E6 and HLA‐A*2402 was found to induce IFN‐γ production by specific CTLs. Tetramer analysis further revealed that induction of E6 49–57 ‐specific T cells was possible in 5 of 7 patients with HPV‐16‐positive high grade cervical intraepithelial neoplasia or cervical cancer by in vitro stimulation with E6 49–57 peptide. Thus, these findings together indicate that E6 49–57 is a candidate epitope for immunotherapy and immunological monitoring of such patients. © 2006 Wiley‐Liss, Inc.